Bradley B. Pua, M.D.

Vascular and Interventional Radiology

Locations and Appointments

Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

*Indicates this doctor is no longer accepting new patients with this insurance plan.

  • HMO
  • Medicare
  • PPO
  • EPO/POS
  • CHP
  • Blue Access
  • Blue Connection
  • EPO
  • HMO
  • Mediblue (Senior)
  • PPO
  • CBP
  • Medicaid
  • Medicare
  • Freedom
  • Liberty
  • Medicare Advantage
  • Metro/Core/Charter
  • Community Plan
  • Medicare
  • HMO
  • Medicare
Personal Statement

Interventional Radiology is a rapidly evolving and innovative field on the forefront of offering minimally invasive techniques for disease treatment.   Our mission is to critically evaluate the ways we deliver care to incorporate advanced imaging tools to guide more targeted treatments increasing quality of life. 

Biographical Info

Bradley B. Pua, M.D.

 - Chief, Division of Interventional Radiology

- Director of the Lung Cancer Screening Program 

- Director, Radiology Consultation Services

Dr. Pua obtained a B.S. degree in Chemistry from New York University (NYU) and continued at NYU School of Medicine where he was awarded his M.D. degree. He completed three years of surgical residency at New York University Medical Center prior to deciding to pursue a career in Interventional Radiology and subsequently completed a fellowship in Interventional Radiology at NewYork-Presbyterian Hospital-Weill Cornell Campus & Memorial Sloan Kettering Cancer Center. Dr. Pua remained at Cornell to complete his diagnostic radiology residency and was elected to serve as Chief Resident in his final year.

Dr. Pua's clinical expertise is in Interventional Radiology and performs a variety of interventional procedures including, but not limited to: arterial embolizations, stent placements, tumor ablations, biopsies and vascular access. His interests include both pediatric interventions and minimally invasive cancer therapy, with a particular focus on thoracic tumors.

Dr. Pua has co-founded and lead a multidisciplinary vascular anomalies group to provide logitudinal care and treatment for vascular ailments such as hemangiomas, arterio-venous malformations, venous anomalies and lymphatic malformations. 

Through the lung screening program, Dr. Pua has been able to streamline the diagnosis and downstream treatment pathways for pateints being followed or diagnosed with lung nodules offering curative treatment at the earliest stages.  He has participated and initiated several trials and continues to be involed in developing and treating primary and secondary (metastatic) lung tumors minimally invasively, with techniques called percutaneous ablation (radio frequency, microwave, cryoablation, pulse electric field ablation).

Board Certifications
American Board of Radiology (Diagnostic Radiology)
American Board of Radiology (Vascular & Interventional Radiology)
Clinical Expertise
Lung Cancer
Tumor Embolization
Pulmonary Arteriovenous Malformation
Radiofrequency Ablation
Ablation of Lung Lesion
Vascular Malformation
Lymphangiogram
Lymphangiography
Lung Biopsy
Low Dose Computed Tomography of Lungs For Lung Cancer Screening
Screening For Lung Cancer
CT Lung Screening
AVM (Arteriovenous Malformation)
Arteriovenous Malformation (AVM)
Languages
English
Education 
  • M.D.
    New York University School of Medicine
    2003
  • B.S.
    New York University
    1999
Appointments 
  • Associate Attending Radiologist
    NewYork-Presbyterian Hospital
  • Associate Professor of Radiology
    Weill Cornell Medical College, Cornell University
  • Associate Professor of Radiology in Cardiothoracic Surgery
    Weill Cornell Medical College, Cornell University

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

Advisory/Scientific Board Member: 
GE Healthcare
Proprietary Interest: 
Oxford University Press Inc.
Other Interest: 
Galvanize Therapeutics, Inc.